Poloxamer 182 (L62)
Based on 1 Customer Validation
Poloxamer 182 (L62) can be used as an excipient, such as Emulsifier, solubilizer, lubricant, etc. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
For research use only. We do not sell to patients.
- CAS No.: 9003-11-6
- Molecular Weight:2500(Average)
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-D1005A
Poloxamer 188Linear Copolymer -
HY-D1005
Poloxamer 407 (F127)LPL Receptor Inhibitor -
HY-D1005H
Poloxamer 188 (F68)Nonionic Linear Copolymer -
HY-D1005A6
Poloxamer 124 (L44)Biochemical Assay Agent -
HY-D1005A22
Poloxamer 338 (F108)Biochemical Assay Agent -
HY-D1005A25
Poloxamer 403 (P123)Biochemical Assay Agent -
HY-D1005A23
Poloxamer 401 (L121)Biochemical Assay Agent -
HY-D1005A10
Poloxamer 184 (L64)Biochemical Assay Agent -
HY-D1005B
Poloxamer 237 (F87)Alcohol Substance -
HY-D1005A2
Poloxamer 105 (L35)Biochemical Assay Agent -
HY-D1005A8
Poloxamer 181 (L61)Biochemical Assay Agent -
HY-D1005K
Poloxamer L64Biochemical Assay Reagent
Biological Activity
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 9003-11-6
-
Appearance Liquid (Density: 1.018 g/cm3)
-
Molecular Weight 2500(Average)
-
Color Colorless to light yellow
-
SMILES
CC.[H(OCH2CH2)x(OCH2CH)y(OCH2CH2)zOH].[CH3]
-
Synonyms
PEG-PPG-PEG, 2500(Average Mn)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Protocol for Pharmacokinetic Study
Pharmacokinetic studies quantify how an organism handles a drug over time through absorption, distribution, metabolism, and excretion, and the core experimental readout is the concentration-time profile of parent drug and, when relevant, metabolites in biological matrices such as plasma, whole blood, urine, bile, or tissue. Pharmacokinetic analysis links dose, route, exposure, clearance, half-life, distribution, bioavailability, and systemic exposure to drug efficacy and toxicity hypotheses rather than measuring a signaling pathway directly. The literature links pharmacokinetics to drug-development phenotypes by showing that drug metabolism and pharmacokinetics influence compound progression, exposure-response interpretation, safety margins, dosing strategy, and failure risk during discovery and development. DMPK science contributes to compound optimization by integrating physicochemical properties, in vitro metabolism, transporter behavior, in vivo exposure, and pharmacodynamic contex
Purity & Documentation
-
Data Sheet (265 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99. [Content Brief]
[2]. Carvalho GC, et al. Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections. Int J Pharm. 2021 Jun 1;602:120635. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Poloxamer 182 (L62) Related Classifications
HY-D1005F Related Classifications
Powered by Bioz